Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates.
about
Promising bone-related therapeutic targets for rheumatoid arthritis.Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies.A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis.Systemic but no local effects of combined zoledronate and parathyroid hormone treatment in experimental autoimmune arthritis.Inhibition of TNF-α Reverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy.Bone fragility beyond strength and mineral density: Raman spectroscopy predicts femoral fracture toughness in a murine model of rheumatoid arthritisAnthraquinone Glycoside Aloin Induces Osteogenic Initiation of MC3T3-E1 Cells: Involvement of MAPK Mediated Wnt and Bmp Signaling.Depression and osteoporosis: epidemiology and potential mediating pathways.Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.Effects of depression and antidepressant medications on hip fracture: A population-based cohort study in Taiwan.Rheumatoid arthritis in the elderly and its relationship with periodontitis: a review.PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production.The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.Association between use of benzodiazepines and risk of fractures: a meta-analysis.Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies.
P2860
Q33554023-B8CCFB93-AD10-42E4-BA97-B382873853B4Q34214948-EDE71E54-6FA2-4746-B303-BBED80C7922CQ34413330-1A43FA24-F136-465D-9183-36DD2A1A0226Q35122997-990DB7E4-BA8B-444C-9B57-056A22FD9C5AQ35744929-579CD561-386E-4ECE-82C4-6E5D642F93F6Q36597970-AF24A828-0AC3-4681-A349-9447FFFB4753Q36640401-DD9CE528-7C47-4933-A307-4433E1264E14Q36925842-9FF4A463-268E-4A8F-87CB-0216E93A1871Q37062092-909A7008-336A-4C8C-A549-34DCD5754B1FQ37256907-4DB6DF6A-6553-49FF-8728-2DDD74E2EDE5Q38093215-56EF229A-1BF0-47F8-A506-3311EA4CBD67Q38308220-2F8B2802-BEB1-400A-91F1-C542C1775018Q41989650-741E4B25-0AE1-46B2-A1B9-A6343E775CE9Q43727102-08CA2AA5-9D7C-481D-A58D-023138D32B53Q48576448-D62CA043-14E5-4E79-A1C9-F6ED3C22B2F8
P2860
Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Bone loss in inflammatory arth ...... proaches with bisphosphonates.
@ast
Bone loss in inflammatory arth ...... proaches with bisphosphonates.
@en
type
label
Bone loss in inflammatory arth ...... proaches with bisphosphonates.
@ast
Bone loss in inflammatory arth ...... proaches with bisphosphonates.
@en
prefLabel
Bone loss in inflammatory arth ...... proaches with bisphosphonates.
@ast
Bone loss in inflammatory arth ...... proaches with bisphosphonates.
@en
P1476
Bone loss in inflammatory arth ...... proaches with bisphosphonates.
@en
P2093
Evan Romas
P304
P356
10.1016/J.BERH.2005.06.008
P577
2005-12-01T00:00:00Z